Andrew M Evens

Inhibition of Bromodomain Proteins for the Treatment of Human Diffuse Large B-cell Lymphoma

Hong Zhang, J. Bradner, S. Trabucco, 2014, Clinical Cancer Research.

The Research on Adverse Drug Events and Reports (RADAR) project.

Matthew H Samore, Jonathan R Nebeker, Kenneth R Carson, 2005, JAMA.

Pure red-cell aplasia and epoetin therapy.

Allen R Nissenson, Stefano Luminari, Benjamin Kim, 2004, The New England journal of medicine.

Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.

Lynn Hlatky, Afshin Beheshti, Jaya Sharma, 2016, Cancer research.

Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer

A. Evens, Andrew M Evens, 2004, Current opinion in oncology.

A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma

Ying Luan, J. Vose, L. Gordon, 2015, Clinical Cancer Research.